Paige
Digital pathology AI applications for cancer pathology, including Paige Prostate.
Last updated: June 14, 2026
Back to directoryDigital pathology platform that combines anatomic and clinical pathology AI workflows, image management, custom AI tools, and laboratory integrations.
Labs evaluating a unified pathology AI platform across multiple specimen, slide, cytology, microbiology, hematology, and workflow automation needs.
Compare within workflow: Digital pathology · comparison shortlist · source index
Product-specific review. These product-specific signals summarize what the cited sources imply before treating Techcyte Fusion as safe for a local clinical, operational, or research workflow.
| Regulatory / FDA | Treat as high-risk pathology AI and digital pathology infrastructure. Match each module to the exact geography, specimen type, scanner, intended use, and current regulatory status before clinical deployment. |
|---|---|
| Privacy | Review BAA terms, image hosting, DICOM metadata, LIS integration, user access, audit logs, support access, retention, deletion, subprocessors, and whether model-development or partner workflows use customer images. |
| Evidence | Require module-specific validation on local slides, stains, scanners, sample prep, and lab populations. Measure pathologist override rates, missed findings, false positives, turnaround time, and drift after launch. |
| Workflow | Best governed through pathologist-supervised review, laboratory validation, quality management, IT/security review, LIS integration testing, downtime procedures, and clear rules for AI output in final reports. |
Techcyte describes Fusion as a unified anatomic and clinical pathology AI platform with products for AP, frozen section, cervical cytology, parasitology, bacteriology, hematology, and organ donation workflows. Its site says Fusion includes image optimization, custom workflows and AI tools, IMS/viewer/storage, reporting and LIS integration, and compliance references including FDA, CE, HIPAA, ISO, GDPR, and SOC2. The footer states Techcyte is CE-IVDD marked in Europe and research use only in the US; buyers should verify current module-specific labeling before clinical use.
Not for: Autonomous diagnosis, unvalidated AI algorithms, or US clinical use where a module is research-use-only or the deployed version lacks the required local authorization.
Use these links to confirm current claims, terms, regulatory status, pricing, and deployment requirements.